Centogene to participate in upcoming conferences in february in the lead up to rare disease day

Cambridge, mass. and rostock, germany and berlin, feb. 07, 2023 (globe newswire) -- centogene n.v. (nasdaq: cntg), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced its partnering conference schedule for february 2023, with a focus on rare and genetic diseases in the lead up to rare disease day (rdd) on february 28th. since 2008, rdd has been held annually on the last day of february and includes a range of activities and initiatives throughout the month. bringing together physicians, patient organizations, researchers, medical companies, and of course, rare disease patients from around the world, rdd raises awareness and generates change for the rare disease community.
CNTG Ratings Summary
CNTG Quant Ranking